Stockreport

Novartis buys Amblyotech to develop tech products for lazy eye [Reuters]

UBISOFT ENTMT UNSP/ADR  (UBSFY) 
PDF Novartis buys Amblyotech to develop tech products for lazy eye ZURICH (Reuters) - Novartis ( NOVN.S ) has bought U.S. software start-up Amblyotech, to develop digital [Read more]